Author:
Wu Guanzhao,Xu Qingliang,Bao Yilei,Liu Yuwei,Li Qian,Fang Zhengyu,Fu Jingyi,Ding Yuhang,Liang Zhiqing,Jiang Tao,Yu Rilei
Publisher
Springer Science and Business Media LLC
Subject
Ocean Engineering,Oceanography
Reference29 articles.
1. Andrews, P. R., Craik, D. J., and Martin, J. L., 1984. Functional group contributions to drug-receptor interactions. Journal of Medicinal Chemistry, 27: 1648–1657.
2. Beinat, C., Banister, S. D., Herrera, M., Law, V., and Kassiou, M., 2015. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia. CNS Drugs, 29: 529–542.
3. Beinat, C., Banister, S. D., Herrera, M., and Kassiou, M., 2016. The recent development of α7 nicotinic acetylcholine receptor (nAChR) ligands as therapeutic candidates for the treatment of central nervous system (CNS) diseases. Current Pharmaceutical Design, 22: 2134–2151.
4. Brams, M., Pandya, A., Kuzmin, D., van Elk, R., Krijnen, L., Yakel, J. L., Tsetlin, V., Smit, A. B., and Ulens, C. A., 2011. A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors. PLoS Computational Biology, 9: e1001034.
5. Bunnelle, W. H., Dart, M. J., and Schrimpf, M. R., 2004. Design of ligands for the nicotinic acetylcholine receptors: The quest for selectivity. Current Topics in Medicinal Chemistry, 4: 299–334.